UCB SA Medical and pharmaceutical research,Anderlecht

1070 Anderlecht- Belgium

Presentation - UCB SA

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

Executives - UCB SA Buy the executives list from same sector

Mr. Jean-Christophe Tellier

CEO - Chief Executive Officer

Location -  UCB SA

Researchdreef 60 - 1070 Anderlecht - Belgium

Key figures -  UCB SA

Activities -  UCB SA

Producer Distributor Service providers

Secondary activities within the Kompass classification

Other classifications (for some countries)

NACE-BEL (BE 2025) : Activities of holding companies (64210)

NACE Rev.2.1 (EU 2025) : Activities of holding companies (6421)

NACE-BEL (BE 2008) : Activities of holding companies (64200)

NACE Rev.2 (EU 2008) : Activities of holding companies (6420)

ISIC 4 (WORLD) : Activities of holding companies (6420)

More about - UCB SA

Discover more on our Website

Kompass membership

Kompass ID? BE0024608

Key information - UCB SA

Business unit Headquarters
Year established 1998
Legal form NV/SA/AG
Activity (BEL25) Activities of holding companies (64210)
Registration No. 2142567276
Registration No. 0403053608
VAT no BE0403053608
No employees (address) Information available as an option
No employees Information available as an option

General Information -  UCB SA

Export area
Central America, North America, South America, Central Asia, Asia-Pacific, Central/East Europe, West. Europe

Other Companies recommended by Kompass: